Mitochondrial oxidative stress pathways in insulin-responsive tissues

Mitochondrial oxidative stress pathways in insulin-responsive tissues encompass the production of reactive oxygen species (ROS) and the subsequent cellular responses within metabolic organs like the liver, skeletal muscle, and adipose tissue (Houstis et al., 2006, Nature). In these tissues, mitochondria are the primary source of ROS, which, at physiological levels, serve as critical signaling molecules for insulin action; however, chronic nutrient excess leads to mitochondrial overload and excessive ROS production (Bhatti et al., 2017, Free Radical Biology and Medicine). This oxidative stress triggers stress-sensitive kinases such as JNK and IKKβ, which phosphorylate insulin receptor substrate (IRS) proteins on serine residues, thereby inhibiting insulin signaling and promoting insulin resistance (Pagel-Langenickel et al., 2010, Advances in Experimental Medicine and Biology). Therapeutic strategies targeting these pathways involve the use of mitochondrial-targeted antioxidants like MitoQ or small molecules that enhance mitochondrial efficiency and biogenesis (Smith & Murphy, 2010, Annals of the New York Academy of Sciences). While these pathways are central to the pathogenesis of Type 2 diabetes and metabolic syndrome, they represent a broad physiological process rather than a single, discrete molecular target (Newsholme et al., 2012, Clinical Science). Consequently, drug development in this area often focuses on specific enzymes within the pathway, such as Superoxide Dismutase or components of the Electron Transport Chain (Rena et al., 2017, Diabetologia).

Other names

Mitochondrial ROS signalingOxidative stress in metabolic tissuesMitochondrial-mediated insulin resistanceMitochondrial redox pathways

Reduction of mitochondrial reactive oxygen species (ROS) production, scavenging of free radicals, and enhancement of antioxidant enzyme activity to restore insulin sensitivity (Houstis et al., 2006; Smith & Murphy, 2010).